ENTITY
Sysmex Corp

Sysmex Corp (6869 JP)

89
Analysis
Health Care • Japan
SYSMEX CORPORATION manufactures reagents and equipment for clinical tests including hematologic (blood) and immune tests. The Company also develops, manufactures, and trades particle analyzers such as blood coagulation analyzer and related software. Manufacturing and sales outside Japan include the United States, EMEA, China and Asia Pacific regions.
more
bearish•PHC Holdings
•29 Sep 2021 12:05

PHC Holdings IPO - Should Have Cut the Price, Not Just the Size

PHC Holdings and its shareholders aim to raise around US$700m, down from US$1.8bn, via selling a mix of primary and secondary shares in its Japan IPO.

Logo
506 Views
Share
bearish•PHC Holdings
•15 Sep 2021 15:17

PHC Holdings Pre-IPO - Peer Comparison

PHC Holdings and its shareholders aim to raise around US$1.8bn via selling a mix of primary and secondary shares in its Japan IPO. The company is...

Logo
405 Views
Share
bullish•Sysmex Corp
•02 Aug 2021 06:11

Japan's Governance: Board Director Training

"Board directors training" is one of the hidden important factors in improving corporate governance, as it is linked to improving the quality of...

Logo
273 Views
Share
bearish•Quantitative Analysis
•13 Aug 2019 16:57

Japan Short Interest - The Numb3rs

The Japan Exchange Group (JPX) publishes a daily report that details the short sell activity by market participants. JPX aggregates broker short...

Logo
619 Views
Share
bearish•ETHK Labs
•01 Jul 2019 17:33

IVD Medical (華檢醫療) IPO Review - More than 70% of IPO Proceeds Used for Dividend and Acquisition

IVD Medical (1931 HK) (IVDM) is looking to raise up to US$157m in its upcoming IPO. IVDM is the result of the Original Group (Shanghai IVD...

Share
x